Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Stem Cell Theranostics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013398
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stem Cell Theranostics Inc (Stem Cell Theranostics) is a biotechnology company that develops genetically-targeted therapies for heart failure. The company discovers and develops novel medicines for heart diseases using stem cell-derived, patient-specific cardiac disease models. It also develops a discovery platform that focuses on the generation and use of stem cell-derived, cardiac disease models in drug screening and therapeutic development. The company’s stem cell technology provide development of research and development productivity and controlling clinical development costs. It offers partnerships with healthcare institutes, research center and drug development companies. Stem Cell Theranostics is headquartered in Redwood, California, the US.

Stem Cell Theranostics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Stem Cell Theranostics Enters into Agreement with Capella BioScience 10
Stem Cell Theranostics Enters into Research Agreement with Thermo Fisher Scientific 11
Licensing Agreements 12
iPS Academia Enters into Licensing Agreement with Stem Cell Theranostics 12
Stem Cell Theranostics Enters into Agreement with Stanford University 13
Stem Cell Theranostics Inc – Key Competitors 14
Stem Cell Theranostics Inc – Key Employees 15
Stem Cell Theranostics Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stem Cell Theranostics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Stem Cell Theranostics Enters into Agreement with Capella BioScience 10
Stem Cell Theranostics Enters into Research Agreement with Thermo Fisher Scientific 11
iPS Academia Enters into Licensing Agreement with Stem Cell Theranostics 12
Stem Cell Theranostics Enters into Agreement with Stanford University 13
Stem Cell Theranostics Inc, Key Competitors 14
Stem Cell Theranostics Inc, Key Employees 15

★海外企業調査レポート[Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Davos Life Science Pte Ltd:企業の戦略・SWOT・財務情報
    Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report Summary Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cytune Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Cytune Pharma SAS (Cytune) is a developer of immunotherapeutic agents for the treatment of cancer and infectious diseases. The company’s product portfolio includes recombinant proteins and monoclonal antibodies. Its CYP0150 is a recombinant protein, which decreases metastasis numbers, tumor …
  • Fortress Biotech Inc (FBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Fortress Biotech Inc (Fortress), formerly Coronado Biosciences Inc is a biopharmaceutical company that develops and commercializes pharmaceutical and biotechnology products. The company offers products in the areas of dermatology, cancer, pain management and autoimmune diseases, among others …
  • Imugene Ltd (IMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Imugene Ltd (Imugene) is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immune-oncology. The company focuses on developing immunotherapies for the treatment of HER-2+ gastric and breast cancer. The HER-2 receptor works on surface of various t …
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Cerner Corp (CERN):企業の財務・戦略的SWOT分析
    Cerner Corp (CERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Autodesk Inc:企業のM&A・事業提携・投資動向
    Autodesk Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Autodesk Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Norwegian Energy Company ASA (NOR):企業の財務・戦略的SWOT分析
    Summary Norwegian Energy Company ASA (Noreco) is an upstream oil and gas company which carries out exploration, production and recovery of hydrocarbon resources. The company focuses on the development of oil and gas reserves; reservoir management and drilling activities; and acquisition of Shell’s u …
  • Delta Apparel, Inc. (DLA):企業の財務・戦略的SWOT分析
    Delta Apparel, Inc. (DLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sigma-Tau HealthScience USA, Inc:企業の戦略・SWOT・財務情報
    Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report Summary Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • S Chand And Company Limited (SCHAND):企業の財務・戦略的SWOT分析
    S Chand And Company Limited (SCHAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PSE Kinsale Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary PSE Kinsale Energy Ltd (Kinsale Energy), formerly Marathon Oil Ireland Limited, carries out the production and storage of natural gas from its facilities off the Old Head of Kinsale. The company operates Kinsale Head, Ballycotton, Seven Heads and Southwest Kinsale gas fields in the Celtic Se …
  • Sisaf Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Armune BioScience Inc:製品パイプライン分析
    Summary Armune BioScience Inc (Armune) is a medical device company that develops and commercializes molecular diagnostic and prognostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests fo …
  • Envision Healthcare Corp:戦略・SWOT・企業財務分析
    Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report Summary Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • UniQure NV (QURE):製薬・医療:M&Aディール及び事業提携情報
    Summary UniQure NV (UniQure) develops and markets gene therapy products. The company develops adeno-associated virus based gene therapies using its gene technology platform. UniQure offers clinical and preclinical programs for lipoprotein lipase deficiency, hemophilia A and B, Huntington’s disease, …
  • BAB, Inc.:企業の戦略・SWOT・財務情報
    BAB, Inc. - Strategy, SWOT and Corporate Finance Report Summary BAB, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Saudi Industrial Export Company (4140):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Export Company (SIEC) is a chemical providing company that imports, exports and sales specialty chemicals, fertilizers, industrial materials and commodities. The company's fertilizers include diammonium phosphate, sulphur, urea, triple super phosphate, granular triple super …
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆